Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Sweden
  4. Nasdaq Stockholm
  5. Infant Bacterial Therapeutics AB (publ)
  6. Summary
    IBT B   SE0008015259

INFANT BACTERIAL THERAPEUTICS AB (PUBL)

(IBT B)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Stockholm
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
79.2(c) 76.3(c) 78.8(c) 75.8(c) 76.9 Last
20 848 18 748 6 019 2 071 3 764 Volume
-2.22% -3.66% +3.28% -3.81% +1.45% Change
More quotes
Estimated financial data (e)
Sales 2019 - - -
Net income 2019 -46,3 M -5,39 M -5,39 M
Net cash position 2019 495 M 57,7 M 57,7 M
P/E ratio 2019 -34,7x
Yield 2019 -
Sales 2020 - - -
Net income 2020 -72,0 M -8,39 M -8,39 M
Net cash position 2020 423 M 49,3 M 49,3 M
P/E ratio 2020 -17,5x
Yield 2020 -
Capitalization 851 M 99,2 M 99,1 M
EV / Sales 2019 -
EV / Sales 2020 -
Nbr of Employees 8
Free-Float 89,5%
More Financials
Company
Infant Bacterial Therapeutics AB is a Sweden-based company, which is primarily involved in the pharmaceutical industry. The Company develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants. 
Sector
Pharmaceuticals
Calendar
10/29 | 02:00amEarnings Release
More about the company
All news about INFANT BACTERIAL THERAPEUTICS AB (PUBL)
09/13INFANT BACTERIAL THERAPEUTICS : announces that a new patent is granted in Mexico
AQ
09/10INFANT BACTERIAL THERAPEUTICS : today announces that a new patent is granted in ..
AQ
09/10Infant Bacterial Therapeutics Announces the Mexican Patent Office Grants New ..
CI
08/25INFANT BACTERIAL THERAPEUTICS : Recruitment of the smallest infants in the Conne..
AQ
08/25Infant Bacterial Therapeutics AB Announces Recruitment of the Smallest Infant..
CI
08/16INFANT BACTERIAL THERAPEUTICS AB : (publ) Interim Management Statement, January ..
AQ
08/13INFANT BACTERIAL THERAPEUTICS AB : (publ) Interim Management Statement, January ..
AQ
08/13Infant Bacterial Therapeutics AB Publ Reports Earnings Results for the Second..
CI
08/13Infant Bacterial Therapeutics AB Announces Interim Management Statement for t..
CI
07/13INFANT BACTERIAL THERAPEUTICS AB : appoints Marie-Louise Alamaa as new CFO
AQ
07/13Infant Bacterial Therapeutics AB Announces CFO Changes, Effective from August..
CI
05/20INFANT BACTERIAL THERAPEUTICS : CFO leaves the company
AQ
05/20Infant Bacterial Therapeutics AB Announces CFO Changes
CI
05/06INFANT BACTERIAL THERAPEUTICS : Annual General Meeting of Infant Bacterial Thera..
AQ
05/05INFANT BACTERIAL THERAPEUTICS : Annual General Meeting of Infant Bacterial Thera..
AQ
More news
News in other languages on INFANT BACTERIAL THERAPEUTICS AB (PUBL)

- No features available -

More news
Chart INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Duration : Period :
Infant Bacterial Therapeutics AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INFANT BACTERIAL THERAPEUTICS AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Staffan Strömberg Chief Executive Officer
Marie-Louise Alamaa Chief Financial Officer
Peter Michael Rothschild Chairman
Eamonn Connolly Chief Scientific Officer
Jonas Rastad Chief Medical Officer